Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312024-01-01truefalse5holding company5falsefalse 11273887 2024-01-01 2024-12-31 11273887 2023-01-01 2023-12-31 11273887 2024-12-31 11273887 2023-12-31 11273887 c:Director7 2024-01-01 2024-12-31 11273887 d:CurrentFinancialInstruments 2024-12-31 11273887 d:CurrentFinancialInstruments 2023-12-31 11273887 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 11273887 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 11273887 d:ShareCapital 2024-12-31 11273887 d:ShareCapital 2023-12-31 11273887 d:RetainedEarningsAccumulatedLosses 2024-12-31 11273887 d:RetainedEarningsAccumulatedLosses 2023-12-31 11273887 c:OrdinaryShareClass1 2024-01-01 2024-12-31 11273887 c:OrdinaryShareClass1 2024-12-31 11273887 c:OrdinaryShareClass1 2023-12-31 11273887 c:FRS102 2024-01-01 2024-12-31 11273887 c:Audited 2024-01-01 2024-12-31 11273887 c:FullAccounts 2024-01-01 2024-12-31 11273887 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11273887 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11273887 6 2024-01-01 2024-12-31 11273887 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 11273887














AMBULNZ UK LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

 
AMBULNZ UK LTD
 

CONTENTS



Page
Statement of Financial Position
1
Notes to the Financial Statements
2 - 4


 
AMBULNZ UK LTD
REGISTERED NUMBER:11273887

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 4 
15,177,539
15,177,539

Current assets
  

Debtors: amounts falling due within one year
 5 
262,736
250,000

Creditors: amounts falling due within one year
 6 
(15,455,521)
(15,433,739)

Net current liabilities
  
 
 
(15,192,785)
 
 
(15,183,739)

  

Net liabilities
  
(15,246)
(6,200)


Capital and reserves
  

Called up share capital 
 7 
1,000
1,000

Profit and loss account
  
(16,246)
(7,200)

  
(15,246)
(6,200)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




A Burns
Director

Date: 19 September 2025

The notes on pages 2 to 4 form part of these financial statements.

Page 1

 
AMBULNZ UK LTD
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Ambulnz UK Ltd is a limited liability company incorporated in England and Wales with its registered office at 44 Broadway, Burrell House, Stratford, London E15 1XH.
The principal activity of the company was of an intermediate holding company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Exemption from preparing consolidated financial statements

The Company is a parent company that is also a subsidiary included in the consolidated financial statements of a larger group by a parent undertaking established under the law of a state other than the United Kingdom and is therefore exempt from the requirement to prepare consolidated financial statements under section 401 of the Companies Act 2006.

 
2.3

Valuation of investments

Investments in subsidiaries are measured at net realisable value.

 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment.

 
2.5

Creditors

Short-term creditors are measured at the transaction price.


3.


Employees




The average monthly number of employees, including directors, during the year was 5 (2023 - 5).

Page 2

 
AMBULNZ UK LTD
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Fixed asset investments





Investments in subsidiary companies

£



Cost


At 1 January 2024
15,177,539



At 31 December 2024
15,177,539





5.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
250,000
250,000

Prepayments and accrued income
12,736
-

262,736
250,000



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Amounts owed to group undertakings
15,451,921
14,957,272

Other creditors
-
475,067

Accruals and deferred income
3,600
1,400

15,455,521
15,433,739


Citibank holds a fixed and floating charge over all company assets in respect of loans provided to the group companies.


7.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



1,000 (2023 - 1,000) Ordinary shares of £1 each
1,000
1,000


Page 3

 
AMBULNZ UK LTD
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Controlling party

The immediate parent undertaking is Ambulnz UK LLC, whose registered office address is 685 Third Avenue, 9th Floor, New York, NY 10017. The ultimate controlling party is DocGo Inc., a publicly listed company on the NASDAQ and whose registered address is 685 Third Avenue, 9th Floor, New York, NY 10017. DocGo is a US based healthcare company providing a range of medical services to public and the private customers across the USA and UK. The financial results can be found at DocGo.com.


9.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 19 September 2025 by Hazel Young (Senior Statutory Auditor) on behalf of Sopher + Co LLP.

 
Page 4